These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23572424)

  • 1. Multiple gene polymorphisms can improve prediction of nonvertebral fracture in postmenopausal women.
    Lee SH; Lee SW; Ahn SH; Kim T; Lim KH; Kim BJ; Cho EH; Kim SW; Kim TH; Kim GS; Kim SY; Koh JM; Kang C
    J Bone Miner Res; 2013 Oct; 28(10):2156-64. PubMed ID: 23572424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
    Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P
    J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Bone Mineral Density and Fragility Fracture by Genetic Profiling.
    Ho-Le TP; Center JR; Eisman JA; Nguyen HT; Nguyen TV
    J Bone Miner Res; 2017 Feb; 32(2):285-293. PubMed ID: 27649491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common and rare variants in the exons and regulatory regions of osteoporosis-related genes improve osteoporotic fracture risk prediction.
    Lee SH; Kang MI; Ahn SH; Lim KH; Lee GE; Shin ES; Lee JE; Kim BJ; Cho EH; Kim SW; Kim TH; Kim HJ; Yoon KH; Lee WC; Kim GS; Koh JM; Kim SY
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2400-11. PubMed ID: 25119311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia.
    Hwang JY; Lee SH; Kim GS; Koh JM; Go MJ; Kim YJ; Kim HC; Kim TH; Hong JM; Park EK; Lee JY; Kim SY
    Bone; 2009 Dec; 45(6):1098-103. PubMed ID: 19651257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic risk factors identified in populations of European descent do not improve the prediction of osteoporotic fracture and bone mineral density in Chinese populations.
    Li YM; Peng C; Zhang JG; Zhu W; Xu C; Lin Y; Fu XY; Tian Q; Zhang L; Xiang Y; Sheng V; Deng HW
    Sci Rep; 2019 Apr; 9(1):6086. PubMed ID: 30988369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel sequence variations in the CER1 gene are strongly associated with low bone mineral density and risk of osteoporotic fracture in postmenopausal women.
    Koromila T; Dailiana Z; Samara S; Chassanidis C; Tzavara C; Patrinos GP; Aleporou-Marinou V; Kollia P
    Calcif Tissue Int; 2012 Jul; 91(1):15-23. PubMed ID: 22543871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic profiling of decreased bone mineral density in an independent sample of Caucasian women.
    Xiao X; Roohani D; Wu Q
    Osteoporos Int; 2018 Aug; 29(8):1807-1814. PubMed ID: 29713799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of IL-15 polymorphisms with bone mineral density in postmenopausal Korean women.
    Koh JM; Oh B; Ha MH; Cho KW; Lee JY; Park BL; Shin HD; Bae MA; Kim HJ; Hong JM; Kim TH; Shin HI; Lee SH; Kim GS; Kim SY; Park EK
    Calcif Tissue Int; 2009 Nov; 85(5):369-78. PubMed ID: 19756346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced osteoporotic fracture prediction in postmenopausal women using Bayesian optimization of machine learning models with genetic risk score.
    Wu Q; Dai J
    J Bone Miner Res; 2024 May; 39(4):462-472. PubMed ID: 38477741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication.
    Riancho JA; Olmos JM; Pineda B; García-Ibarbia C; Pérez-Núñez MI; Nan DN; Velasco J; Cano A; García-Pérez MA; Zarrabeitia MT; González-Macías J
    Eur J Endocrinol; 2011 Jan; 164(1):123-31. PubMed ID: 20926594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of osteopenic women at high risk of fracture: the OFELY study.
    Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of FLT3 polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women.
    Koh JM; Oh B; Lee JY; Lee JK; Kimm K; Park BL; Shin HD; Lee IK; Kim HJ; Hong JM; Kim TH; Kim GS; Kim SY; Park EK
    J Bone Miner Res; 2007 Nov; 22(11):1752-8. PubMed ID: 17620055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vitamin D receptor gene polymorphisms in the bone mineral density of Greek postmenopausal women with low calcium intake.
    Stathopoulou MG; Dedoussis GV; Trovas G; Theodoraki EV; Katsalira A; Dontas IA; Hammond N; Deloukas P; Lyritis GP
    J Nutr Biochem; 2011 Aug; 22(8):752-7. PubMed ID: 21115334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk.
    Frediani B; Acciai C; Falsetti P; Baldi F; Filippou G; Siagkri C; Spreafico A; Galeazzi M; Marcolongo R
    Calcif Tissue Int; 2006 Oct; 79(4):223-9. PubMed ID: 16969597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
    Watts NB; Geusens P; Barton IP; Felsenberg D
    J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing bone mineral density in postmenopausal women with and without vertebral fracture and its value in recognizing high-risk individuals.
    Heidari B; Hoshmand S; Hajian K; Heidari P
    East Mediterr Health J; 2010 Aug; 16(8):868-73. PubMed ID: 21469569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
    Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
    J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.